Oscor Inc has announced it carrying out a $10m expansion of its medical device manufacturing facilities at Oscor Caribe in Las Americas Industrial Free Zone Park, Dominican Republic.
The expansion is adding a total of 200,000 sqft cleanroom manufacturing amenities in two phases over the next four years to its current footprint of 110,000 sqft. The new facilities will add state of the art ISO Class 7 and 8 cleanroom manufacturing space featuring leading-edge capabilities in cleanroom assembly, injection moulding, extrusion, laser processing, cleanroom packaging and sterilisation.
The new site represents a $10 million investment over four years to expand and upgrade Oscor's contract manufacturing capacity and low concentration EO sterilisation technology.
The new facilities will add state of the art ISO Class 7 and 8 cleanroom manufacturing space
These additions are being made to support Florida-based Oscor's growing OEM and contract manufacturing services.
Phase 1
Oscor started construction of phase 1 in the spring of 2020. The new facility will be Oscor's third manufacturing plant in the Dominican Republic.
The new facilities will be ISO certified to highest quality and sustainability standards, incorporating the latest in intelligent and autonomous technologies. Oscor Caribe's new plant will produce implantable pacing and neuromodulation leads, next-generation introducer and guiding sheaths, high-performance medical components and contract manufacturing, packaging and sterilisation services for other medical device companies.
Oscor has currently two manufacturing plants in the US, located in Tampa Bay Florida, two in the Dominican Republic, and sales and distribution office in Palm Harbor US & Düsseldorf, Germany. Oscor products are regulatory approved and sold worldwide in over 100 countries, while servicing leading medical device companies with fully integrated contract manufacturing and sterilisation services.
